Journal article

βc receptor antagonism mitigates sarcoidosis granuloma formation by targeting inflammatory signals and aberrant lipid metabolism

H Wang, DJ Tumes, S Keam, JW Lim, QA Nguyen, R Vlahos, J McQualter, A Quek, C Whyte, H Pant, TR Hercus, NJ Wilson, PN Reynolds, CM Owczarek, AF Lopez, S Bozinovski, KH Yip

Frontiers in Immunology | Frontiers Media SA | Published : 2025

Open access

Abstract

Introduction: Sarcoidosis is a multisystem chronic inflammatory disorder of unknown etiology that primarily affects the lungs and currently has no cure. Macrophages are central to granuloma formation, and βc cytokines tightly regulate their activation and function. This study investigates the role of the βc receptor in granuloma development and evaluates βc antagonism as a potential therapeutic strategy for sarcoidosis. Methods: We utilized an in vitro model of human granuloma formation using sarcoidosis patient human peripheral blood mononuclear cells (PBMCs) and an in vivo vimentin-induced pulmonary sarcoidosis model in unique humanized βc transgenic (hβcTg) mice to assess the efficacy of ..

View full abstract

University of Melbourne Researchers